Search

everythinglearnresearchcommunity

for

Search:↓

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

ECM1-modified stem cells can effectively treat liver cirrhosis.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

Muse cells from human bone marrow help reduce symptoms of atopic dermatitis in mice.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Stem cell therapy from umbilical cords may help treat atopic dermatitis.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

A systems biology approach helps improve mesenchymal stromal cell therapies by mapping interactions and identifying treatment targets.

Polysulfonic acid mucopolysaccharide can reduce skin scarring.

MSC exosome therapy improved hair quality in patients with acquired trichorrhexis nodosa.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

3D spheroid culture makes stem cells better at reducing inflammation.

Mesenchymal stem cells and their secretions might help treat chronic skin inflammation in atopic dermatitis.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.